Active Ingredient(s):Taliglucerase Alfa FDA Approved: * May 1, 2012 Pharm Company: *PROTALIX LTD Category:Enzymes
Taliglucerase alfa, sold under the brand name Elelyso among others, is a biopharmaceutical medication developed by Protalix and Pfizer.[full citation needed] The drug, a recombinant glucocerebrosidase used to treat Gaucher's disease, is the first plant-made pharmaceutical to win approval by the U.S. Food and Drug Administration (FDA).
Each vial has 200 units of taliglucerase alfa.
* May have multiple approval dates, manufacturers, or labelers.
Elelyso 200 U/5ml Intravenous Injection, Powder, Lyophilized, for Solution